⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
Class Action Lawsuit Reminder from Pomerantz LLP for Investors of ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
Class Action Lawsuit Reminder from Pomerantz LLP for Investors of ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
SPRY INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026
globenewswire.com
SPRY
SPRY DEADLINE: ROSEN, TRUSTED INVESTOR RIGHTS COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 5 Deadline in Securities Class Action – SPRY
globenewswire.com
SPRY
Class Action Filed Against ARS Pharmaceuticals, Inc. (SPRY) Over Securities Violations - Contact Levi & Korsinsky Today
accessnewswire.com
SPRY
Robbins LLP Reminds SPRY Stockholders of the Pending October 5, 2026 Lead Plaintiff Deadline in the Securities Class Action Against ARS Pharmaceuticals Inc.
globenewswire.com
SPRY
Pomerantz LLP Updates Shareholders on Legal Action Brought Against ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
Kaplan Fox Alerts Investors of ARS Pharmaceuticals Inc. (SPRY) to an Upcoming Deadline of October 5, 2026 in the Securities Class Action Ready to Announce with Confidence?
newsfilecorp.com
SPRY
Securities Lawsuit Alert: ARS Pharmaceuticals, Inc. (SPRY) - Contact Levi & Korsinsky Before October 5, 2026
accessnewswire.com
SPRY
SPRY STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ARS Pharmaceuticals Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
SPRY